Eur J Pharmacol. 2025 May 3;999:177702. doi: 10.1016/j.ejphar.2025.177702. Online ahead of print.
ABSTRACT
Hypertension, a chronic condition marked by elevated blood pressure, poses a significant health risk globally. This review explores the potential of sodium nitrate supplementation to enhance nitric oxide (NO) bioavailability and reduce oxidative stress in patients with hypertension. NO, known for its vasodilatory properties, plays a crucial role in maintaining endothelial function and cardiovascular health. Additionally, this study provides a comprehensive analysis of current research on the mechanisms through which sodium nitrate enhances nitric oxide (NO) levels, thereby improving endothelial function, reducing oxidative stress, and lowering blood pressure. The findings underline sodium nitrate's promising capacity to reduce dependence on conventional antihypertensive therapies, offering a cost-effective strategy for enhancing cardiovascular outcomes. Effective dosage ranges, such as 6-12 mmol/day (approximately 510-1020 mg nitrate), derived from dietary sources like leafy greens and beetroot juice, are proposed as practical solutions. Future studies are warranted to substantiate these benefits, refine dosing protocols, and establish guidelines for safe and effective clinical application. Integrating sodium nitrate into treatment frameworks could significantly advance hypertension management, improve patient quality of life, and reduce healthcare expenditures.
PMID:40324575 | DOI:10.1016/j.ejphar.2025.177702